Many Don't Know Key Facts About Zika Virus Transmission

Share this content:
Many Don't Know Key Facts About Zika Virus Transmission
Many Don't Know Key Facts About Zika Virus Transmission

WEDNESDAY, March 30, 2016 (HealthDay News) -- Many individuals are unaware of the exact nature of Zika virus transmission, according to a report published online March 29 by the Harvard T.H. Chan School of Public Health.

Researchers conducted a nationally representative poll of 1,275 adults, including 105 who live in households where someone is pregnant or is considering getting pregnant within the next 12 months.

The researchers found that 23 percent of respondents in households where someone was either pregnant or considering getting pregnant were not aware of the correlation between Zika virus and microcephaly; 20 percent believed there was a vaccine for Zika. Thirty-nine percent of all respondents believed that if a non-pregnant woman gets infected by Zika virus it is likely to harm subsequent pregnancies. Although 87 percent of all respondents knew that Zika virus was transmitted by mosquitoes, 22, 29, and 40 percent, respectively, were unaware that Zika could be transmitted to a fetus during pregnancy, that it could be transmitted through blood transfusions, and that it could be transmitted sexually. Thirty-one percent believed that it was transmitted through coughing and sneezing.

"We have a key window before the mosquito season gears up in communities within the United States mainland to correct misperceptions about Zika virus so that pregnant women and their partners may take appropriate measures to protect their families," Gillian SteelFisher, Ph.D., director of the poll and research scientist in the Department of Health Policy and Management at Harvard Chan School, said in a statement.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths